DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

References

Acunzo J, Thirion S, Roche C. et al.
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.

Cancer Res 2008;
68: 10163-10170 10.1158/0008-5472.can-08-1857

Download Bibliographical Data

Search in:
Access: